Financial Post EN

Health Coalition demands disclosures & end to Grifols’ for-profit blood plasma contract following reports of deaths, harm, non-compliance

TORONTO, March 13, 2026 (GLOBE NEWSWIRE) — The Ontario and Manitoba Health Coalitions held a press conference this morning to respond to a report from CBC about two patients who died in Winnipeg after having their blood plasma harvested at centres owned by for-profit pharmaceutical corporation Grifols. Another report followed, of a man who is suing, alleging kidney damage […]

Mar 13, 2026 &03421313202631; 20:42 UTC financialpost.com Trending 3/5

Read original on financialpost.com ↗

↘

Negative for markets

Sentiment score: -75/100

High impact Immediate effect (hours)

WHAT THIS MEANS

Health coalitions in Ontario and Manitoba are demanding disclosure and termination of Grifols' for-profit blood plasma contracts following CBC reports of patient deaths and injuries at Grifols-owned centers. The controversy involves allegations of non-compliance, inadequate safety protocols, and regulatory failures in plasma collection operations.

AI CONFIDENCE

85% Very high

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

GRFS

GRFSStock

Expected to decline

Regulatory scrutiny, contract termination risk, litigation exposure, and reputational damage from safety violations and patient deaths

⇅

S&P 500

^GSPCIndex

High volatility expected

Healthcare sector volatility due to regulatory concerns affecting pharmaceutical and biotech companies

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Short Grifols (GRFS) with elevated conviction given immediate regulatory pressure, contract termination risk, and litigation exposure. Monitor for additional provincial health authority actions and potential class-action lawsuits that could materially impact operations and profitability.

KEY SIGNALS

Patient deaths at for-profit plasma centersRegulatory non-compliance allegationsGovernment contract termination demandsLitigation risk from kidney damage claimsReputational damage and public health scrutinyPotential contract cancellations in Canada

SECTORS INVOLVED

HealthcarePharmaceuticalsBiotechnologyMedical Services

Analysis generated on Mar 16, 2026 at 13:13 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Financial Post. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Health Coalition demands disclosures & end to Grifols’ for-profit blood plasma contract following reports of deaths, harm, non-compliance

RELATED INTELLIGENCE